Voyager is a Massachusetts-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of a range of diseases.Read more
Abeona is Voyager's #1 rival. Abeona is a Public company that was founded in New York, New York in 1974. Like Voyager, Abeona also works within the Pharmaceuticals field. Abeona has 47 fewer employees vs. Voyager.
Adverum is perceived as one of Voyager's biggest rivals. Adverum was founded in 2006, and is headquartered in Redwood City, California. Like Voyager, Adverum also operates in the Pharmaceuticals sector. Adverum generates $150.9M less revenue vs. Voyager.
Voyager's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 625.9M. Over the last four quarters, Voyager's revenue has decreased by 77.3%. Specifically, in Q1 2021's revenue was $6.5M; in Q4 2020, it was $6.5M; in Q3 2020, it was $117.8M; in Q2 2020, Voyager's revenue was $28.7M.
No recent acquisitions found related to Voyager
No recent investments found related to Voyager